Potential Side Effects and Considerations More perspective on Kyleena and breastfeeding can make the topic easier to follow by connecting earlier points with a few simple takeaways. Progestin-only methods like Kyleena are not associated with this same risk.
WHO Classification for Kyleena and Breastfeeding
If breastfeeding is the intention, this waiting period does not pose a problem, as fertility can return unpredictably, making contraception necessary even before the first postpartum period. The recommended window for immediate postpartum insertion is typically within 10 minutes of delivering the placenta.
The hormone it releases, levonorgestrel, is a progestin, which is a synthetic form of the natural hormone progesterone. The systemic exposure of an infant to the progestin from Kyleena is orders of magnitude lower than what is seen with progestin-only pills (the mini-pill), which are also considered safe during lactation.
WHO Classification on Kyleena and Breastfeeding Safety
The Kyleena intrauterine system (IUS) presents a specific set of considerations for lactating individuals, primarily concerning its progestin component and potential transfer into breast milk. Understanding Kyleena's Mechanism and Hormone Profile Kyleena is a levonorgestrel-releasing intrauterine system designed to prevent pregnancy for up to five years.
More About Kyleena and breastfeeding
Looking at Kyleena and breastfeeding from another angle can help expand the discussion and give readers a second clear paragraph under the same section.
More perspective on Kyleena and breastfeeding can make the topic easier to follow by connecting earlier points with a few simple takeaways.
